- Report
- November 2021
France
From €3320EUR$3,500USD£2,792GBP
- Report
- November 2021
Japan, United States, ... Japan, United States, Europe, Global
From €23242EUR$24,500USD£19,541GBP
- Report
- November 2021
Canada, Mexico, North America Canada, Mexico, North America
From €9012EUR$9,500USD£7,577GBP
- Report
- November 2021
Middle East
From €9012EUR$9,500USD£7,577GBP
- Report
- November 2021
Latin America
From €13755EUR$14,500USD£11,565GBP
- Report
- November 2021
Europe
From €23242EUR$24,500USD£19,541GBP
- Report
- November 2021
Asia Pacific
From €13755EUR$14,500USD£11,565GBP
- Report
- November 2021
Global
From €32728EUR$34,500USD£27,517GBP
- Report
- October 2022
- 280 Pages
Global
From €3500EUR$3,690USD£2,943GBP
The Thrombin Time test is a coagulation and hemostasis test used to measure the time it takes for a clot to form in a sample of blood. It is used to detect deficiencies in the coagulation cascade, such as those caused by heparin, fibrinogen, or factor deficiencies. The test is also used to monitor the effectiveness of anticoagulant therapy.
The Thrombin Time market is a subset of the larger coagulation and hemostasis testing market. It is a growing market, driven by the increasing prevalence of cardiovascular diseases, as well as the need for more accurate and reliable testing methods. The market is expected to benefit from the development of new technologies and products, such as automated systems and point-of-care testing.
Some of the major companies in the Thrombin Time market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, and Ortho Clinical Diagnostics. Show Less Read more